Literature DB >> 8395006

A region of the 85-kilodalton (kDa) subunit of phosphatidylinositol 3-kinase binds the 110-kDa catalytic subunit in vivo.

A Klippel1, J A Escobedo, Q Hu, L T Williams.   

Abstract

Phosphatidylinositol (PI) 3-kinase is a heterodimer consisting of an 85-kDa subunit (p85) and 110-kDa subunit (p110). The 85-kDa noncatalytic subunit, which contains two Src homology 2 (SH2) domains, one SH3 domain, and a domain homologous to the carboxy terminus of the breakpoint cluster region gene product, is known to mediate the association of the PI 3-kinase complex with activated growth factor receptors. We previously demonstrated that the C-terminal SH2 domain of p85 is responsible for the interaction of PI 3-kinase with phosphorylated platelet-derived growth factor receptor. To define the region in p85 that directs the complex formation with the PI 3-kinase catalytic subunit, a series of truncated p85 mutants was analyzed for association with p110 in vivo. We found that a fragment of p85 containing the region between the two SH2 domains was sufficient to promote the interaction with p110 in vivo. The complex between the fragment of p85 and p110 had PI 3-kinase activity that was comparable in magnitude to the activity of p110 associated with full-length p85. The binding with p110 was abolished when this domain in p85 was disrupted. These results identify a novel structural and functional element that is responsible for localizing the catalytic subunit of PI 3-kinase.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8395006      PMCID: PMC360276          DOI: 10.1128/mcb.13.9.5560-5566.1993

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  30 in total

1.  Phosphatidylinositol 3-kinase: structure and expression of the 110 kd catalytic subunit.

Authors:  I D Hiles; M Otsu; S Volinia; M J Fry; I Gout; R Dhand; G Panayotou; F Ruiz-Larrea; A Thompson; N F Totty
Journal:  Cell       Date:  1992-08-07       Impact factor: 41.582

2.  Interactions of polyomavirus middle T with the SH2 domains of the pp85 subunit of phosphatidylinositol-3-kinase.

Authors:  M Yoakim; W Hou; Y Liu; C L Carpenter; R Kapeller; B S Schaffhausen
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

3.  The C-terminal SH2 domain of p85 accounts for the high affinity and specificity of the binding of phosphatidylinositol 3-kinase to phosphorylated platelet-derived growth factor beta receptor.

Authors:  A Klippel; J A Escobedo; W J Fantl; L T Williams
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  A tightly associated serine/threonine protein kinase regulates phosphoinositide 3-kinase activity.

Authors:  C L Carpenter; K R Auger; B C Duckworth; W M Hou; B Schaffhausen; L C Cantley
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

6.  Insulin-dependent formation of a complex containing an 85-kDa subunit of phosphatidylinositol 3-kinase and tyrosine-phosphorylated insulin receptor substrate 1.

Authors:  K Yonezawa; H Ueda; K Hara; K Nishida; A Ando; A Chavanieu; H Matsuba; K Shii; K Yokono; Y Fukui
Journal:  J Biol Chem       Date:  1992-12-25       Impact factor: 5.157

7.  Modification of the 85-kilodalton subunit of phosphatidylinositol-3 kinase in platelet-derived growth factor-stimulated cells.

Authors:  W M Kavanaugh; A Klippel; J A Escobedo; L T Williams
Journal:  Mol Cell Biol       Date:  1992-08       Impact factor: 4.272

8.  In vivo binding properties of SH2 domains from GTPase-activating protein and phosphatidylinositol 3-kinase.

Authors:  J A Cooper; A Kashishian
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

9.  Interaction of the p85 subunit of PI 3-kinase and its N-terminal SH2 domain with a PDGF receptor phosphorylation site: structural features and analysis of conformational changes.

Authors:  G Panayotou; B Bax; I Gout; M Federwisch; B Wroblowski; R Dhand; M J Fry; T L Blundell; A Wollmer; M D Waterfield
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

10.  Tyr721 regulates specific binding of the CSF-1 receptor kinase insert to PI 3'-kinase SH2 domains: a model for SH2-mediated receptor-target interactions.

Authors:  M Reedijk; X Liu; P van der Geer; K Letwin; M D Waterfield; T Hunter; T Pawson
Journal:  EMBO J       Date:  1992-04       Impact factor: 11.598

View more
  27 in total

1.  Negative regulation of PI 3-kinase by Ruk, a novel adaptor protein.

Authors:  I Gout; G Middleton; J Adu; N N Ninkina; L B Drobot; V Filonenko; G Matsuka; A M Davies; M Waterfield; V L Buchman
Journal:  EMBO J       Date:  2000-08-01       Impact factor: 11.598

2.  The structure of the inter-SH2 domain of class IA phosphoinositide 3-kinase determined by site-directed spin labeling EPR and homology modeling.

Authors:  Zheng Fu; Eliah Aronoff-Spencer; Jonathan M Backer; Gary J Gerfen
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

3.  The phosphoinositide 3-OH kinase/AKT2 pathway as a critical target for farnesyltransferase inhibitor-induced apoptosis.

Authors:  K Jiang; D Coppola; N C Crespo; S V Nicosia; A D Hamilton; S M Sebti; J Q Cheng
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

4.  Phosphatidylinositol 3-kinase mediates epidermal growth factor-induced activation of the c-Jun N-terminal kinase signaling pathway.

Authors:  S K Logan; M Falasca; P Hu; J Schlessinger
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

5.  PI3K is negatively regulated by PIK3IP1, a novel p110 interacting protein.

Authors:  Zhenqi Zhu; Xin He; Carla Johnson; John Stoops; Amanda E Eaker; David S Stoffer; Aaron Bell; Reza Zarnegar; Marie C DeFrances
Journal:  Biochem Biophys Res Commun       Date:  2007-04-24       Impact factor: 3.575

6.  Regulation of Class IA PI 3-kinases: C2 domain-iSH2 domain contacts inhibit p85/p110alpha and are disrupted in oncogenic p85 mutants.

Authors:  Haiyan Wu; S Chandra Shekar; Rory J Flinn; Mirvat El-Sibai; Bijay S Jaiswal; K Ilker Sen; Vasantharajan Janakiraman; Somasekar Seshagiri; Gary J Gerfen; Mark E Girvin; Jonathan M Backer
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-13       Impact factor: 11.205

7.  Cyclin D1 expression mediated by phosphatidylinositol 3-kinase through mTOR-p70(S6K)-independent signaling in growth factor-stimulated NIH 3T3 fibroblasts.

Authors:  N Takuwa; Y Fukui; Y Takuwa
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

8.  ErbB3 (HER3) interaction with the p85 regulatory subunit of phosphoinositide 3-kinase.

Authors:  N J Hellyer; K Cheng; J G Koland
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

9.  Structure of a specific peptide complex of the carboxy-terminal SH2 domain from the p85 alpha subunit of phosphatidylinositol 3-kinase.

Authors:  A L Breeze; B V Kara; D G Barratt; M Anderson; J C Smith; R W Luke; J R Best; S A Cartlidge
Journal:  EMBO J       Date:  1996-07-15       Impact factor: 11.598

10.  SUMOylation modulates the stability and function of PI3K-p110β.

Authors:  Ahmed El Motiam; Carlos F de la Cruz-Herrera; Santiago Vidal; Rocío Seoane; Maite Baz-Martínez; Yanis H Bouzaher; Emilio Lecona; Mariano Esteban; Manuel S Rodríguez; Anxo Vidal; Manuel Collado; Carmen Rivas
Journal:  Cell Mol Life Sci       Date:  2021-04-08       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.